当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2008年第20期
编号:11641986
代谢综合征患者血浆抵抗素水平与胰岛素抵抗变化的研究(2)
http://www.100md.com 2008年7月15日 黄少坤 谢 文 叶建红
第1页

    参见附件(213KB,2页)。

     [2]Vettor R, Milan G, Rossata M,et al. Review article: adipocytokines and insulin resistance[J]. Aliment Pharmacol Ther,2005,22(Suppl 2): 3-10.

    [3]Rajala MW,Obici S,Scherer PE,et al. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production[J]. J Clin Invest, 2003, 111(2):225-230.

    [4]Kitagawa Y,Bujo H,Takahashi K,et al. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin[J].Diabetologia,2004,47(10):847-853.

    [5]宋秀霞(译),纪立农(校). 国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华糖尿病杂志, 2005,13(3):175-177.

    [6]Furuhashi M,Ura N, Higashiura K,et al. Circulating resistin levels in essential hypertension[J]. Clin Endocrinol (Oxf),2003,59(4): 507-510.

    [7]Mary SB, Joseph M, Devaney RJ,et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance[J].J Clin Endocrinol Metab,2006,91(1): 64-68.

    [8]Degawa-Yamauchi M,Bovenkerk JE,Juliar BE,et al. Serum resistin (FIZZ3) protein is increased in obese humans[J].J Clin Endocrinol Metab, 2003, 88(11): 5452-5455.

    (收稿日期:2008-03-16)

    注:本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文

您现在查看是摘要介绍页,详见PDF附件(213KB,2页)